The International
Journal of Generic Drugs
This is an authoritative Pharmaceutical Journal specializing
in Generic Drug Development for the Pharmaceutical Drug Industry. Published
in three world zones the Journal contains state-of-the-art technical
articles on formulation and procedures, checklists, SOPs, diagrams,
protocols and flow charts simplifying generic drug development and validation
requirements and the relevant FDA's Office of Generic Drugs rules and
EU regulations pertaining to ANDA submissions and EU Dossiers and Expert
Reports.
A special subscription for institutions includes a print, CD and e-mail
electronic copy. The final volume print edition (issue #8) contains
the full year's volume on a CD ROM as well.
Generic Drug Development
Letter
A free bimonthly e-mail copy of the popular Generic Drug Development
Letter for the pharmaceutical industry is available on request, to pharmaceutical
, research and development personnel from contact
- Snapshot of global
clients
The International
Journal of Drug Development (Series)
An authoritative Pharmaceutical Journal specializing in drug development
from pre-formulation to process validation for specific drug products
to the Pharmaceutical Drug Industry. (Go to
Table of Contents for all target drugs covered). Every
aspect of Drug Development is thoroughly evaluated. A must for Pharmaceutical
R&D Units. Gives the Ins-and-Outs each issue of the CMC development
of a specific generic product.
The International
Journal of Drug Development contains articles on technical
procedures, process designs, formulation, checklists, drug design development
SOPs, diagrams and flow charts that simplify the drug development process requirements
and the relevant FDA's CDER and CBER's rules and regulations pertaining to New
Drug Applications and Abbreviated Submissions.
24 Volume Handbook Series of Generic Drug Development
Locum publishes a unique user-friendly series of
Handbooks of Generic Drug Development. Each Handbook is a
dosage-form specific Handbook that simplifies the overall generic
drug development process and the related FDA's Office of Generic Drugs and EU
agencies rules and regulations.
The Handbooks and the Journal are interrelated in data sourcing.
Journal topics each year are updated, summarized and edited and incorporated
into the individual chapters of the dosage-specific
Handbooks of Generic Drug Development .
[Each volume is published in two parts approx. 950 -1000 pages per part
/ weight 2 - 4 kg per book]
Go to catalog
for additional information on each specific Handbook.
120+ READY-TO-GO Generic
Drug Development Series
Proven market tested
generic formulations and processes. All products in the series are currently
on the US and /or EU market. Generic development and data research is
collated on worldwide basis from contributing IAGIM scientists, researchers,
developers, involving IAGIM Development with innovative and generic
firms, universities, via joint development ventures and academic institutions.
Each generic product is extensively evaluated against the US RLD or
the EU equivalents in the EU ranging from comparative dissolution profiles
to accelerated and long term stability with degradation and impurity
profiles, incorporating fully stressed stability indicating HPLC assays.
The Journal supports an extensive data base of results, (stability,
dissolution, assay & impurity profiles etc.), SOPs and validation
protocols and results which are published in both the Journals and Drug
Development Handbooks.
Each of the fourteen International Journals publishes
three (3) ISSN formats per journal (U S | Euro | Pacific Rim) totaling
14 x 8 individual issues per year. Development Data is available as
CMCs Dossiers either electronically or by print to IAGIM members only.
(Go to Download
Area for full list - File #46).
Handbooks
in the 24 Volume Series Consists of two parts
per volume
Part
One - Drug Development Handbook covering the A-Z of each dosage form
development
Part Two - Drug Formulation Handbook covering the A-Z of each dosage
form development + Full development Dossier + Expert Reports
Electronic and print Handbooks are updated annually - via a Continual
Update Program. The Handbook's objective is to make it easy by continually
updating developers & researchers in a presentation and format that
can be rapidly grasped and digested. Contributing scientists and authors
are acknowledged in the Handbook series.
Other Publications from Locum Press
Locum Press publishes
concise and comprehensive Drugs Off-Patent Reports, Handbooks on Drug
Development, Drug Development SOPs, Analytical method and Methods validation
Extensive PAI Programs and unique GMP Audits Checklists containing diagrams
and flow charts that simplify the overall generic drug development program.
Extensive Drugs Off-Patents Reports - Electronic DOP
Reports - free
to IAGIM members dealing with all Drugs Off-Patent to the year 2020.
The Journal and Handbook Series aim to continually
update Pharmaceutical Generic Researchers and Scientists for all
practical drug development applications. Simplifies and expedites the
generic drug development process and clarifies the relevant FDA's Office
of Generic Drugs numerous rules and regulations.
Global
Database of API Manufacturers
Ready-To-Go
Series - CMC Know-how Technology
|